Conference Coverage

DDW: HBV, tuberculosis reactivations rare in IBD patients on biologic therapy

Publish date: May 18, 2015

 

AT DDW 2015

References

His financial disclosures include receiving consulting, speaking, teaching, and/or advisory fees from Janssen, Aptalis, and AbbVie.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

PAS: Oral antibiotics better for complicated pneumonia post discharge than PICC
MDedge Family Medicine
PAS: New approaches for cystic fibrosis–related diabetes in development
MDedge Family Medicine
PAS: Mind-body practices benefit teens with chronic illnesses
MDedge Family Medicine
FDA panel supports approval of combination drug for cystic fibrosis
MDedge Family Medicine
PAS: Fewer tests improve care in neurologically impaired children with pneumonia
MDedge Family Medicine
Albuterol costs soared after CFC inhaler ban
MDedge Family Medicine
Asymptomatic carotid stenosis and central sleep apnea linked
MDedge Family Medicine
OARSI: Pain of knee osteoarthritis is worse for smokers
MDedge Family Medicine
ATS: Nintedanib found effective for IPF up to 76 weeks
MDedge Family Medicine
ATS: High-dose nitric oxide looks promising for infants with bronchiolitis
MDedge Family Medicine